Rank | Gene Set | Z-score |
---|---|---|
1 | immunoglobulin mediated immune response (GO:0016064) | 6.80520365 |
2 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 5.87638782 |
3 | B cell mediated immunity (GO:0019724) | 5.34542673 |
4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.29277303 |
5 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.97098935 |
6 | * T cell costimulation (GO:0031295) | 4.95084719 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91189798 |
8 | * lymphocyte costimulation (GO:0031294) | 4.88220650 |
9 | detection of bacterium (GO:0016045) | 4.78980718 |
10 | * cellular response to interferon-gamma (GO:0071346) | 4.77609399 |
11 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.65380226 |
12 | positive regulation of mast cell degranulation (GO:0043306) | 4.65380226 |
13 | positive regulation of mast cell activation (GO:0033005) | 4.59847313 |
14 | detection of other organism (GO:0098543) | 4.51931359 |
15 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.47306858 |
16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44467677 |
17 | mature B cell differentiation involved in immune response (GO:0002313) | 4.35897082 |
18 | T-helper 1 type immune response (GO:0042088) | 4.33063858 |
19 | regulation of antigen processing and presentation (GO:0002577) | 4.31642965 |
20 | neutrophil activation involved in immune response (GO:0002283) | 4.20508904 |
21 | * response to interferon-gamma (GO:0034341) | 4.18256277 |
22 | positive regulation by symbiont of host defense response (GO:0052509) | 4.14552673 |
23 | modulation by symbiont of host defense response (GO:0052031) | 4.14552673 |
24 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.14552673 |
25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.14552673 |
26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.14552673 |
27 | modulation by symbiont of host immune response (GO:0052553) | 4.14552673 |
28 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.09633482 |
29 | regulation of hypersensitivity (GO:0002883) | 4.04113547 |
30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.03240393 |
31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98766681 |
32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97488632 |
33 | mature B cell differentiation (GO:0002335) | 3.97315779 |
34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90008168 |
35 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86210161 |
36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.84443850 |
37 | detection of external biotic stimulus (GO:0098581) | 3.81069151 |
38 | B cell receptor signaling pathway (GO:0050853) | 3.73730362 |
39 | negative regulation of B cell proliferation (GO:0030889) | 3.72847647 |
40 | positive regulation of type 2 immune response (GO:0002830) | 3.70338047 |
41 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.68307353 |
42 | regulation of mast cell degranulation (GO:0043304) | 3.66711812 |
43 | macrophage activation involved in immune response (GO:0002281) | 3.64114364 |
44 | defense response to protozoan (GO:0042832) | 3.63805658 |
45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.60843225 |
46 | regulation of mast cell activation (GO:0033003) | 3.53256034 |
47 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.52979852 |
48 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.50840341 |
49 | microglial cell activation (GO:0001774) | 3.49900028 |
50 | response to peptidoglycan (GO:0032494) | 3.49847932 |
51 | positive regulation of leukocyte degranulation (GO:0043302) | 3.42755094 |
52 | type I interferon signaling pathway (GO:0060337) | 3.41425061 |
53 | cellular response to type I interferon (GO:0071357) | 3.41425061 |
54 | regulation of B cell proliferation (GO:0030888) | 3.39539441 |
55 | regulation of T cell tolerance induction (GO:0002664) | 3.38872051 |
56 | positive regulation of interferon-gamma production (GO:0032729) | 3.38081597 |
57 | response to type I interferon (GO:0034340) | 3.38035519 |
58 | positive thymic T cell selection (GO:0045059) | 3.35465763 |
59 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.35167265 |
60 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.35035262 |
61 | myeloid dendritic cell activation (GO:0001773) | 3.34650568 |
62 | negative regulation of cell killing (GO:0031342) | 3.33417194 |
63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.33417194 |
64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.31917571 |
65 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.28888574 |
66 | myeloid dendritic cell differentiation (GO:0043011) | 3.27715688 |
67 | response to protozoan (GO:0001562) | 3.26076150 |
68 | detection of biotic stimulus (GO:0009595) | 3.24003974 |
69 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20533310 |
70 | mast cell activation (GO:0045576) | 3.18501100 |
71 | positive regulation of B cell proliferation (GO:0030890) | 3.15172815 |
72 | production of molecular mediator of immune response (GO:0002440) | 3.15092084 |
73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.12735419 |
74 | * T cell receptor signaling pathway (GO:0050852) | 3.12555072 |
75 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.11411552 |
76 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.06185679 |
77 | regulation of tolerance induction (GO:0002643) | 3.05122950 |
78 | myeloid cell activation involved in immune response (GO:0002275) | 3.04494169 |
79 | detection of molecule of bacterial origin (GO:0032490) | 2.99489606 |
80 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.94009295 |
81 | positive regulation of B cell mediated immunity (GO:0002714) | 2.93945684 |
82 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.93945684 |
83 | * positive regulation of T cell activation (GO:0050870) | 2.92907396 |
84 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.90493279 |
85 | positive regulation of T cell proliferation (GO:0042102) | 2.89928501 |
86 | positive regulation of lymphocyte proliferation (GO:0050671) | 2.89543728 |
87 | positive regulation of mononuclear cell proliferation (GO:0032946) | 2.88980224 |
88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.88979028 |
89 | positive regulation of leukocyte proliferation (GO:0070665) | 2.88675040 |
90 | positive regulation of B cell differentiation (GO:0045579) | 2.88405867 |
91 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.87406953 |
92 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.86272369 |
93 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82504081 |
94 | response to host immune response (GO:0052572) | 2.82435397 |
95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.82435397 |
96 | negative regulation of interleukin-12 production (GO:0032695) | 2.82425042 |
97 | positive regulation of interleukin-17 production (GO:0032740) | 2.81628874 |
98 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.81237917 |
99 | regulation of interferon-gamma production (GO:0032649) | 2.80244272 |
100 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.79958785 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.67692372 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.67823463 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.50281910 |
4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.59130108 |
5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.15386148 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.00718857 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.80185657 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.50446842 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.18985660 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07824265 |
11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.91073391 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.88312470 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75442648 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64994541 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59655658 |
16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.54007600 |
17 | MYB_26560356_Chip-Seq_TH2_Human | 2.43294372 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42334658 |
19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32738473 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04026449 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03948441 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01738748 |
23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95701165 |
24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.94523432 |
25 | MYC_22102868_ChIP-Seq_BL_Human | 1.93710491 |
26 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.89908209 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 1.86228210 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76252579 |
29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75919449 |
30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75907323 |
31 | MAF_26560356_Chip-Seq_TH1_Human | 1.74508494 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72608122 |
33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69907378 |
34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67621957 |
35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60865460 |
36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59522621 |
37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52446191 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51898394 |
39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50481505 |
40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49759930 |
41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44000727 |
42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41445523 |
43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39492732 |
44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38762130 |
45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36466152 |
46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31525617 |
47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31464244 |
48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22841981 |
49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21038051 |
50 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20674811 |
51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20038934 |
52 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18331800 |
53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18168255 |
54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16067289 |
55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14930703 |
56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13969641 |
57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13559632 |
58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12962852 |
59 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11055008 |
60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10763025 |
61 | MAF_26560356_Chip-Seq_TH2_Human | 1.10145341 |
62 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06505838 |
63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04223982 |
64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00926178 |
65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00782627 |
66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00451548 |
67 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00346829 |
68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98927189 |
69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94506618 |
70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94395679 |
71 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92544648 |
72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92178266 |
73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92140069 |
74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92103180 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88953400 |
76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87646515 |
77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.86160883 |
78 | P300_27268052_Chip-Seq_Bcells_Human | 0.84342566 |
79 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81866838 |
80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81677892 |
81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80535099 |
82 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80348307 |
83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79595679 |
84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76737229 |
85 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75737910 |
86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75447897 |
87 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75307592 |
88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75205979 |
89 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.73192507 |
90 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72643083 |
91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.72364458 |
92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70906480 |
93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.70501894 |
94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70437028 |
95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70075678 |
96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69112402 |
97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.68878201 |
98 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68714140 |
99 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.67901880 |
100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.67527391 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 6.04797582 |
2 | MP0005671_abnormal_response_to | 4.71460045 |
3 | MP0001800_abnormal_humoral_immune | 3.58360480 |
4 | MP0000685_abnormal_immune_system | 3.40806553 |
5 | MP0003303_peritoneal_inflammation | 3.40744406 |
6 | MP0003724_increased_susceptibility_to | 3.23404748 |
7 | MP0001790_abnormal_immune_system | 3.23269017 |
8 | MP0005387_immune_system_phenotype | 3.23269017 |
9 | MP0005000_abnormal_immune_tolerance | 3.21749141 |
10 | MP0009785_altered_susceptibility_to | 3.13150971 |
11 | MP0002452_abnormal_antigen_presenting | 3.06581908 |
12 | MP0002148_abnormal_hypersensitivity_rea | 2.83021382 |
13 | MP0002723_abnormal_immune_serum | 2.81098079 |
14 | MP0003436_decreased_susceptibility_to | 2.80357280 |
15 | MP0005025_abnormal_response_to | 2.65036536 |
16 | MP0002419_abnormal_innate_immunity | 2.56772614 |
17 | MP0001819_abnormal_immune_cell | 2.55992264 |
18 | MP0002420_abnormal_adaptive_immunity | 2.50135542 |
19 | MP0010155_abnormal_intestine_physiology | 2.48831312 |
20 | MP0002166_altered_tumor_susceptibility | 2.41857191 |
21 | MP0006082_CNS_inflammation | 2.05713270 |
22 | MP0005451_abnormal_body_composition | 1.93268333 |
23 | MP0000716_abnormal_immune_system | 1.89492920 |
24 | MP0003763_abnormal_thymus_physiology | 1.86978958 |
25 | MP0001845_abnormal_inflammatory_respons | 1.86492233 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.85338976 |
27 | MP0009764_decreased_sensitivity_to | 1.84360935 |
28 | MP0002398_abnormal_bone_marrow | 1.82157462 |
29 | MP0009333_abnormal_splenocyte_physiolog | 1.77441165 |
30 | MP0003806_abnormal_nucleotide_metabolis | 1.74972076 |
31 | MP0003183_abnormal_peptide_metabolism | 1.74952956 |
32 | MP0001873_stomach_inflammation | 1.72560258 |
33 | MP0002006_tumorigenesis | 1.72509326 |
34 | MP0003075_altered_response_to | 1.69026990 |
35 | MP0005166_decreased_susceptibility_to | 1.68531689 |
36 | MP0003300_gastrointestinal_ulcer | 1.66389877 |
37 | MP0001853_heart_inflammation | 1.65418747 |
38 | MP0002139_abnormal_hepatobiliary_system | 1.62275654 |
39 | MP0003866_abnormal_defecation | 1.60447101 |
40 | MP0004947_skin_inflammation | 1.58129471 |
41 | MP0008469_abnormal_protein_level | 1.49905231 |
42 | MP0009379_abnormal_foot_pigmentation | 1.49164627 |
43 | MP0002405_respiratory_system_inflammati | 1.49100066 |
44 | MP0005464_abnormal_platelet_physiology | 1.47040166 |
45 | MP0002429_abnormal_blood_cell | 1.46181373 |
46 | MP0001533_abnormal_skeleton_physiology | 1.41096522 |
47 | MP0000689_abnormal_spleen_morphology | 1.33919970 |
48 | MP0000858_altered_metastatic_potential | 1.32836959 |
49 | MP0000465_gastrointestinal_hemorrhage | 1.27968010 |
50 | MP0005058_abnormal_lysosome_morphology | 1.22025904 |
51 | MP0003172_abnormal_lysosome_physiology | 1.20952947 |
52 | MP0002722_abnormal_immune_system | 1.17276464 |
53 | MP0002998_abnormal_bone_remodeling | 1.11632442 |
54 | MP0003045_fibrosis | 1.10575532 |
55 | MP0005310_abnormal_salivary_gland | 1.05712294 |
56 | MP0002396_abnormal_hematopoietic_system | 1.05240811 |
57 | MP0005360_urolithiasis | 1.00943195 |
58 | MP0008004_abnormal_stomach_pH | 1.00633045 |
59 | MP0001663_abnormal_digestive_system | 0.99371704 |
60 | MP0000343_altered_response_to | 0.97000546 |
61 | MP0003191_abnormal_cellular_cholesterol | 0.84665895 |
62 | MP0009763_increased_sensitivity_to | 0.84335068 |
63 | MP0000516_abnormal_urinary_system | 0.84195947 |
64 | MP0005367_renal/urinary_system_phenotyp | 0.84195947 |
65 | MP0003448_altered_tumor_morphology | 0.83210319 |
66 | MP0005075_abnormal_melanosome_morpholog | 0.81938953 |
67 | MP0002796_impaired_skin_barrier | 0.80716858 |
68 | MP0004510_myositis | 0.79019367 |
69 | MP0005165_increased_susceptibility_to | 0.78242652 |
70 | MP0001545_abnormal_hematopoietic_system | 0.77404452 |
71 | MP0005397_hematopoietic_system_phenotyp | 0.77404452 |
72 | MP0000249_abnormal_blood_vessel | 0.77250167 |
73 | MP0009643_abnormal_urine_homeostasis | 0.75467565 |
74 | MP0002136_abnormal_kidney_physiology | 0.74959690 |
75 | MP0000490_abnormal_crypts_of | 0.73958647 |
76 | MP0000703_abnormal_thymus_morphology | 0.73669384 |
77 | MP0005670_abnormal_white_adipose | 0.70621068 |
78 | MP0004381_abnormal_hair_follicle | 0.69417357 |
79 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65105836 |
80 | MP0005275_abnormal_skin_tensile | 0.64468049 |
81 | MP0005645_abnormal_hypothalamus_physiol | 0.63862798 |
82 | MP0005535_abnormal_body_temperature | 0.61944679 |
83 | MP0008260_abnormal_autophagy | 0.61418675 |
84 | MP0005085_abnormal_gallbladder_physiolo | 0.61063290 |
85 | MP0001851_eye_inflammation | 0.59008835 |
86 | MP0005381_digestive/alimentary_phenotyp | 0.57948309 |
87 | MP0000604_amyloidosis | 0.56298465 |
88 | MP0002933_joint_inflammation | 0.55958107 |
89 | MP0003795_abnormal_bone_structure | 0.55325394 |
90 | MP0006036_abnormal_mitochondrial_physio | 0.54753699 |
91 | MP0009765_abnormal_xenobiotic_induced | 0.54458081 |
92 | MP0003091_abnormal_cell_migration | 0.53586873 |
93 | MP0003252_abnormal_bile_duct | 0.52802464 |
94 | MP0004264_abnormal_extraembryonic_tissu | 0.52159779 |
95 | MP0008874_decreased_physiological_sensi | 0.49070333 |
96 | MP0000371_diluted_coat_color | 0.48118293 |
97 | MP0001666_abnormal_nutrient_absorption | 0.47851649 |
98 | MP0001765_abnormal_ion_homeostasis | 0.47444924 |
99 | MP0000920_abnormal_myelination | 0.47327055 |
100 | MP0005390_skeleton_phenotype | 0.47305812 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Obstructive lung disease (HP:0006536) | 5.22027853 |
2 | Chronic obstructive pulmonary disease (HP:0006510) | 5.22027853 |
3 | Vasculitis (HP:0002633) | 5.05296131 |
4 | Meningitis (HP:0001287) | 4.79486195 |
5 | Hemoptysis (HP:0002105) | 4.55849899 |
6 | Eczematoid dermatitis (HP:0000976) | 4.33688626 |
7 | Recurrent bacterial skin infections (HP:0005406) | 4.23929027 |
8 | Gastrointestinal stroma tumor (HP:0100723) | 4.14619563 |
9 | Abnormality of the prostate (HP:0008775) | 4.04179281 |
10 | Agammaglobulinemia (HP:0004432) | 4.03339341 |
11 | Pulmonary infiltrates (HP:0002113) | 4.01533466 |
12 | Recurrent abscess formation (HP:0002722) | 3.99609312 |
13 | Restrictive lung disease (HP:0002091) | 3.88044523 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 3.78474193 |
15 | Recurrent sinusitis (HP:0011108) | 3.77815069 |
16 | Abnormality of the pleura (HP:0002103) | 3.70264749 |
17 | Systemic lupus erythematosus (HP:0002725) | 3.68440699 |
18 | Gastrointestinal infarctions (HP:0005244) | 3.65811812 |
19 | Urticaria (HP:0001025) | 3.54560554 |
20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.49885432 |
21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.49885432 |
22 | Emphysema (HP:0002097) | 3.43526376 |
23 | Recurrent fungal infections (HP:0002841) | 3.40921927 |
24 | Abnormality of macrophages (HP:0004311) | 3.40889640 |
25 | Chest pain (HP:0100749) | 3.39496204 |
26 | Gangrene (HP:0100758) | 3.34235118 |
27 | Recurrent bronchitis (HP:0002837) | 3.32944916 |
28 | Recurrent skin infections (HP:0001581) | 3.30765938 |
29 | Skin rash (HP:0000988) | 3.25517537 |
30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20326798 |
31 | Increased IgE level (HP:0003212) | 3.20171400 |
32 | Chronic diarrhea (HP:0002028) | 3.05205338 |
33 | Panhypogammaglobulinemia (HP:0003139) | 3.02586572 |
34 | Acrocyanosis (HP:0001063) | 3.01010732 |
35 | Increased IgM level (HP:0003496) | 2.99909529 |
36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98031770 |
37 | Ureteral stenosis (HP:0000071) | 2.92743795 |
38 | Myositis (HP:0100614) | 2.91865239 |
39 | Recurrent viral infections (HP:0004429) | 2.88637582 |
40 | Colitis (HP:0002583) | 2.87762541 |
41 | Abnormality of complement system (HP:0005339) | 2.86936933 |
42 | Nephritis (HP:0000123) | 2.85342767 |
43 | Glomerulopathy (HP:0100820) | 2.84598714 |
44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.77957767 |
45 | Pulmonary fibrosis (HP:0002206) | 2.77322773 |
46 | Ureteral obstruction (HP:0006000) | 2.77255551 |
47 | Pulmonary embolism (HP:0002204) | 2.75774737 |
48 | Retrobulbar optic neuritis (HP:0100654) | 2.70388410 |
49 | Optic neuritis (HP:0100653) | 2.70388410 |
50 | Lymphopenia (HP:0001888) | 2.68775377 |
51 | Abnormality of the pericardium (HP:0001697) | 2.68005049 |
52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62327647 |
53 | Orchitis (HP:0100796) | 2.62027684 |
54 | IgG deficiency (HP:0004315) | 2.60230567 |
55 | Xerostomia (HP:0000217) | 2.55734368 |
56 | Cellulitis (HP:0100658) | 2.53442321 |
57 | Inflammation of the large intestine (HP:0002037) | 2.48038175 |
58 | Petechiae (HP:0000967) | 2.45346224 |
59 | Abnormality of male internal genitalia (HP:0000022) | 2.44778415 |
60 | Hypergammaglobulinemia (HP:0010702) | 2.43064197 |
61 | Recurrent pneumonia (HP:0006532) | 2.42976237 |
62 | Cerebral palsy (HP:0100021) | 2.42540470 |
63 | Fatigue (HP:0012378) | 2.40880325 |
64 | Increased cerebral lipofuscin (HP:0011813) | 2.40637498 |
65 | IgM deficiency (HP:0002850) | 2.39013217 |
66 | Skin ulcer (HP:0200042) | 2.37573852 |
67 | Polyneuropathy (HP:0001271) | 2.37539259 |
68 | Encephalitis (HP:0002383) | 2.35481422 |
69 | Abnormality of B cell number (HP:0010975) | 2.34617409 |
70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33926349 |
71 | Papilloma (HP:0012740) | 2.33905367 |
72 | Verrucae (HP:0200043) | 2.33905367 |
73 | Epistaxis (HP:0000421) | 2.32464784 |
74 | Osteomyelitis (HP:0002754) | 2.32175576 |
75 | Gastrointestinal inflammation (HP:0004386) | 2.31342133 |
76 | Pruritus (HP:0000989) | 2.29072849 |
77 | IgA deficiency (HP:0002720) | 2.28523573 |
78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.26500869 |
79 | Paresthesia (HP:0003401) | 2.21862103 |
80 | Pustule (HP:0200039) | 2.20734425 |
81 | Purpura (HP:0000979) | 2.18870265 |
82 | Arthralgia (HP:0002829) | 2.17300340 |
83 | Keratoconjunctivitis sicca (HP:0001097) | 2.16024969 |
84 | Anorexia (HP:0002039) | 2.14635895 |
85 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14616467 |
86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14616467 |
87 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14616467 |
88 | Hypertensive crisis (HP:0100735) | 2.14002381 |
89 | Malnutrition (HP:0004395) | 2.12900661 |
90 | Premature loss of primary teeth (HP:0006323) | 2.12751106 |
91 | Abnormality of T cell number (HP:0011839) | 2.11809648 |
92 | Chronic otitis media (HP:0000389) | 2.11549156 |
93 | Arterial thrombosis (HP:0004420) | 2.11225050 |
94 | Thrombophlebitis (HP:0004418) | 2.11091735 |
95 | Spontaneous hematomas (HP:0007420) | 2.10057850 |
96 | B lymphocytopenia (HP:0010976) | 2.08253884 |
97 | Gingivitis (HP:0000230) | 2.05929250 |
98 | Chronic sinusitis (HP:0011109) | 2.03946030 |
99 | Amaurosis fugax (HP:0100576) | 2.03676229 |
100 | Basal ganglia calcification (HP:0002135) | 2.03458870 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BMPR2 | 4.38052970 |
2 | RIPK4 | 4.18282265 |
3 | MAP4K1 | 4.05018386 |
4 | CDK19 | 3.85435644 |
5 | BLK | 3.48485336 |
6 | MAP3K14 | 3.09125561 |
7 | TYK2 | 2.77373108 |
8 | CSF1R | 2.50544510 |
9 | MAP3K12 | 2.43069051 |
10 | KIT | 2.33972568 |
11 | JAK3 | 2.28437747 |
12 | SYK | 2.20108687 |
13 | MAP3K13 | 2.11015536 |
14 | PRPF4B | 2.04219140 |
15 | IKBKB | 1.96594314 |
16 | BTK | 1.84598762 |
17 | TAOK3 | 1.84154819 |
18 | JAK1 | 1.80340642 |
19 | IRAK4 | 1.72400313 |
20 | MATK | 1.70909939 |
21 | LYN | 1.67680177 |
22 | CSK | 1.67463275 |
23 | TBK1 | 1.62479773 |
24 | IKBKE | 1.54690732 |
25 | TLK1 | 1.54237032 |
26 | ERN1 | 1.43139831 |
27 | STK24 | 1.41551156 |
28 | GRK6 | 1.34212617 |
29 | FES | 1.31169778 |
30 | MYLK | 1.30952114 |
31 | TXK | 1.24388717 |
32 | HCK | 1.19227674 |
33 | ITK | 1.17225371 |
34 | FGR | 1.16780040 |
35 | TAOK2 | 1.15039854 |
36 | FGFR4 | 1.14349951 |
37 | TEC | 1.13401357 |
38 | MAP3K3 | 1.11680837 |
39 | SIK2 | 1.09792399 |
40 | RIPK1 | 1.06870472 |
41 | LCK | 1.05321111 |
42 | SIK3 | 1.01770250 |
43 | JAK2 | 1.00889825 |
44 | ZAP70 | 1.00037098 |
45 | FGFR3 | 0.98275078 |
46 | IRAK1 | 0.90107346 |
47 | TRPM7 | 0.86382266 |
48 | EIF2AK3 | 0.83087791 |
49 | NME2 | 0.82109072 |
50 | CDC42BPA | 0.81206639 |
51 | CHUK | 0.80862103 |
52 | OXSR1 | 0.80749016 |
53 | MARK3 | 0.76687314 |
54 | DAPK3 | 0.76446903 |
55 | MST4 | 0.75516653 |
56 | IRAK3 | 0.73943832 |
57 | PRKCQ | 0.73458244 |
58 | ILK | 0.71784848 |
59 | MAP2K3 | 0.70134958 |
60 | PDK1 | 0.65743807 |
61 | SCYL2 | 0.65426061 |
62 | GRK7 | 0.62299791 |
63 | KDR | 0.58464078 |
64 | MAP3K10 | 0.58272492 |
65 | IRAK2 | 0.57809880 |
66 | DDR2 | 0.57663280 |
67 | MAPK7 | 0.55779262 |
68 | ABL1 | 0.54311688 |
69 | PIM1 | 0.54168612 |
70 | TNK2 | 0.53517397 |
71 | HIPK2 | 0.52248486 |
72 | EPHA3 | 0.52005775 |
73 | MAPK12 | 0.49861803 |
74 | PDPK1 | 0.48101390 |
75 | PIK3CG | 0.48061584 |
76 | CCNB1 | 0.48025835 |
77 | PRKCD | 0.47796833 |
78 | DAPK1 | 0.46263679 |
79 | EGFR | 0.45346770 |
80 | MAP4K2 | 0.43547148 |
81 | FYN | 0.42483306 |
82 | LRRK2 | 0.40297964 |
83 | SMG1 | 0.40136622 |
84 | RPS6KA5 | 0.39707165 |
85 | MAP3K1 | 0.39178737 |
86 | NEK9 | 0.37251685 |
87 | IGF1R | 0.36633966 |
88 | PKN1 | 0.35063084 |
89 | EPHB1 | 0.31971633 |
90 | MAPK4 | 0.30007910 |
91 | TAOK1 | 0.29167248 |
92 | PAK4 | 0.27425662 |
93 | MAPK11 | 0.26813414 |
94 | BRD4 | 0.25722460 |
95 | BCKDK | 0.25509552 |
96 | ACVR1B | 0.24909481 |
97 | MAPKAPK2 | 0.24585033 |
98 | INSR | 0.22062763 |
99 | YES1 | 0.20178871 |
100 | PRKG2 | 0.19071252 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Asthma_Homo sapiens_hsa05310 | 6.15259503 |
2 | * Allograft rejection_Homo sapiens_hsa05330 | 5.35685531 |
3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.98339626 |
4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.90023194 |
5 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.66631553 |
6 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.24233529 |
7 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.54736434 |
8 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.15297864 |
9 | * Viral myocarditis_Homo sapiens_hsa05416 | 3.09396792 |
10 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.03448494 |
11 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.88995138 |
12 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.41096820 |
13 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.73678701 |
14 | * Tuberculosis_Homo sapiens_hsa05152 | 1.71168474 |
15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.67071298 |
16 | * Influenza A_Homo sapiens_hsa05164 | 1.50750561 |
17 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.48014666 |
18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44033458 |
19 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.37967978 |
20 | * Phagosome_Homo sapiens_hsa04145 | 1.30315589 |
21 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19327885 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19029516 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14229739 |
24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10391651 |
25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02951682 |
26 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84964016 |
27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80364413 |
28 | Pertussis_Homo sapiens_hsa05133 | 0.78866632 |
29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.73749683 |
30 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69879044 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68216449 |
32 | Measles_Homo sapiens_hsa05162 | 0.65542662 |
33 | Legionellosis_Homo sapiens_hsa05134 | 0.64410511 |
34 | Salmonella infection_Homo sapiens_hsa05132 | 0.60955291 |
35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60917720 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58709225 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55846666 |
38 | Malaria_Homo sapiens_hsa05144 | 0.51133119 |
39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48010186 |
40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47218112 |
41 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.45897639 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44954805 |
43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42969487 |
44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40043809 |
45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39213543 |
46 | Shigellosis_Homo sapiens_hsa05131 | 0.37833370 |
47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37707114 |
48 | Lysosome_Homo sapiens_hsa04142 | 0.32326553 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31597178 |
50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31472923 |
51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30318808 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.27116316 |
53 | Ribosome_Homo sapiens_hsa03010 | 0.27045178 |
54 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26996485 |
55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26956797 |
56 | Platelet activation_Homo sapiens_hsa04611 | 0.26771714 |
57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26408020 |
58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24117915 |
59 | Hepatitis B_Homo sapiens_hsa05161 | 0.23978116 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.21172809 |
61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19836787 |
62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18789745 |
63 | Apoptosis_Homo sapiens_hsa04210 | 0.18302153 |
64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17559475 |
65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.16528044 |
66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15219082 |
67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.15030856 |
68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12651958 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.10269669 |
70 | Proteasome_Homo sapiens_hsa03050 | 0.08925646 |
71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.08650880 |
72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.07695869 |
73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.06841580 |
74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.06379322 |
75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.06215276 |
76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.04029382 |
77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.03312269 |
78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.03213400 |
79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.01038557 |
80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.00903217 |
81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.00392288 |
82 | Amoebiasis_Homo sapiens_hsa05146 | 0.00374847 |
83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.00168022 |
84 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0587626 |
85 | Salivary secretion_Homo sapiens_hsa04970 | -0.0581321 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0520695 |
87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | -0.0519387 |
88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | -0.0508243 |
89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0492271 |
90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | -0.0420234 |
91 | PPAR signaling pathway_Homo sapiens_hsa03320 | -0.0375226 |
92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0361381 |
93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | -0.0286680 |
94 | Tryptophan metabolism_Homo sapiens_hsa00380 | -0.0257389 |
95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0188373 |
96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0167992 |
97 | Endocytosis_Homo sapiens_hsa04144 | -0.0119876 |
98 | Mineral absorption_Homo sapiens_hsa04978 | -0.0075110 |
99 | Bladder cancer_Homo sapiens_hsa05219 | -0.0047206 |
100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | -0.0029027 |